Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Mattei

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|January 15, 2013
TIM-3 as a molecular switch for tumor escape from innate immunityFabrizio Mattei, Giovanna Schiavoni
Iscience|May 30, 2023
Interdisciplinary research in cancer and immunity employing biophysical approachesFabrizio Mattei, Mohit Kumar Jolly
Oncoimmunology|November 1, 2013
The dual role of IRF8 in cancer immunosurveillanceGiovanna Schiavoni, Lucia Gabriele, Fabrizio Mattei
Cells|February 15, 2022
Cancer Immunology: From Molecular Mechanisms to Therapeutic OpportunitiesFabrizio Mattei, Carlos Alfaro, Yona Keisari
Frontiers in Immunology|January 9, 2014
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor ResponseGiovanna Schiavoni, Fabrizio Mattei, Lucia Gabriele
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
A Clonogenic Assay to Quantify Melanoma Micrometastases in Pulmonary TissueFabrizio Mattei, Sara Andreone, Giovanna Schiavoni
Frontiers in Oncology|April 26, 2013
The tumor microenvironment: a pitch for multiple playersGiovanna Schiavoni, Lucia Gabriele, Fabrizio Mattei
Cytokine & Growth Factor Reviews|July 15, 2010
Regulation of immune cell homeostasis by type I interferonsFabrizio Mattei, Giovanna Schiavoni, David F Tough
Frontiers in Immunology|May 25, 2023
Editorial: Non-coding RNA in improving the efficacy of cancer immunotherapyPeixin Dong, Fabrizio Mattei, Mark Andrew Lindsay
Frontiers in Immunology|August 3, 2023
Editorial: Organoids, organs-on-chip, nanoparticles and <i>in silico</i> approaches to dissect the tumor-immune dynamics and to unveil the drug resistance mechanisms to therapy in the tumor microenvironmentFabrizio Mattei, Jason T George, Mohit Kumar Jolly
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|January 15, 2013
TIM-3 as a molecular switch for tumor escape from innate immunityFabrizio Mattei, Giovanna Schiavoni
Iscience|May 30, 2023
Interdisciplinary research in cancer and immunity employing biophysical approachesFabrizio Mattei, Mohit Kumar Jolly
Oncoimmunology|November 1, 2013
The dual role of IRF8 in cancer immunosurveillanceGiovanna Schiavoni, Lucia Gabriele, Fabrizio Mattei
Cells|February 15, 2022
Cancer Immunology: From Molecular Mechanisms to Therapeutic OpportunitiesFabrizio Mattei, Carlos Alfaro, Yona Keisari
Frontiers in Immunology|January 9, 2014
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor ResponseGiovanna Schiavoni, Fabrizio Mattei, Lucia Gabriele
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
A Clonogenic Assay to Quantify Melanoma Micrometastases in Pulmonary TissueFabrizio Mattei, Sara Andreone, Giovanna Schiavoni
Frontiers in Oncology|April 26, 2013
The tumor microenvironment: a pitch for multiple playersGiovanna Schiavoni, Lucia Gabriele, Fabrizio Mattei
Cytokine & Growth Factor Reviews|July 15, 2010
Regulation of immune cell homeostasis by type I interferonsFabrizio Mattei, Giovanna Schiavoni, David F Tough
Frontiers in Immunology|May 25, 2023
Editorial: Non-coding RNA in improving the efficacy of cancer immunotherapyPeixin Dong, Fabrizio Mattei, Mark Andrew Lindsay
Frontiers in Immunology|August 3, 2023
Editorial: Organoids, organs-on-chip, nanoparticles and <i>in silico</i> approaches to dissect the tumor-immune dynamics and to unveil the drug resistance mechanisms to therapy in the tumor microenvironmentFabrizio Mattei, Jason T George, Mohit Kumar Jolly
Pageof 7